Neil Iyengar

In this enlightening discussion, Dr. Emily Gallagher, an endocrinologist focused on metabolic complications of cancer therapy, joins Dr. Neil Iyengar, a breast medical oncologist specializing in targeted therapies. They dive into the nuances of PI3K and AKT inhibitors for hormone receptor-positive metastatic breast cancer. Listeners will learn about the management of common side effects like hyperglycemia and gastrointestinal issues, practical dosing strategies, and the critical role of patient education in ensuring effective treatment.